Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga
The Readout Loud - A podcast by STAT - Thursdays
Categories:
STAT's Rachel Cohrs drops in to talk about the latest updates in drug pricing reform. Then, John Maraganore joins us to talk about his decision to step down as CEO of Alnylam Pharmaceuticals after almost 20 years with the company. We also discuss the latest news in biotech, including the Covid-19 vaccine for kids and Moderna's disappointing earnings call.
